UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
__________________
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
BIOTRICITY INC.
(Exact name of registrant as specified in its charter)
|
Nevada |
|
47-2548273 |
|
(State of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
|
275 Shoreline Drive, Suite 150 Redwood City, California |
|
94065 |
|
(Address of principal executive offices) |
|
(Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
|
Title of each class to be so registered |
|
Name of each exchange on which each class is to be so registered |
|
Not Applicable |
|
Not Applicable |
|
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. ¨ |
|
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. x |
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ¨
Securities Act registration statement or Regulation A offering statement file number to which this form relates:
Securities to be registered pursuant to Section 12(g) of the Act: Common Stock, $0.001 par value
1
Item 1.
Description of Registrant’s Securities to be Registered .
The information regarding the common stock, $0.001 par value, of Biotricity Inc. (the “Company”), as set forth under the caption “Description of Securities” in the Company’s Registration Statement on Form S-1/A (File No. 333-222962) as amended and filed with the Securities and Exchange Commission on March 8, 2018, is incorporated herein by reference.
Item 2. Exhibits.
|
Exhibit No. |
Description |
|
Amended and Restated Articles of Incorporation (filed as Exhibit 3(i) to Current Report on Form 8-K filed on February 3, 2016 and incorporated herein by reference). |
|
|
Amended and Restated By-Laws (filed as Exhibit 3(ii) to Current Report on Form 8-K filed on February 3, 2016 and incorporated herein by reference). |
|
|
Certificate of Designation of Preferences, Rights and Limitations of Special Voting Preferred Stock of Biotricity Inc. (filed as Exhibit 4.1 to Current Report on Form 8-K filed on February 3, 2016 and incorporated herein by reference). |
|
|
Exchangeable Share provisions with respect to the special rights and restrictions attached to Exchangeable Shares (filed as Exhibit 4.2 to Current Report on Form 8-K filed on February 3, 2016 and incorporated herein by reference). |
|
|
|
2
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
BIOTRICITY INC.
Date: July 16, 2019
By: /s/ John Ayanoglou
Name: John Ayanoglou
Title: Chief Executive Officer
3